Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nicol

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Antimicrobial Agents and Chemotherapy|August 5, 2020
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin BCaleb P Skipper, Mucunguzi Atukunda, Anna Stadelman, et al.
The Lancet. Infectious Diseases|July 27, 2019
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trialJoshua Rhein, Kathy Huppler Hullsiek, Lillian Tugume, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases|February 12, 2020
Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and OutcomesKatelyn A Pastick, Ananta S Bangdiwala, Mahsa Abassi, et al.
Open Forum Infectious Diseases|May 13, 2022
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient TrialsSarah M Lofgren, Elizabeth C Okafor, Alanna A Colette, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases PharmacistsElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summaryElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
A national survey of the infectious diseases and antimicrobial stewardship pharmacist workforce in the United States: work settings, characteristics, employment activities, resources and needsElizabeth B Hirsch, David A Mott, Aaron M Gilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical TrialMorris K Rutakingirwa, Caleb P Skipper, Biyue Dai, et al.
The New England Journal of Medicine|June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|August 5, 2020
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin BCaleb P Skipper, Mucunguzi Atukunda, Anna Stadelman, et al.
The Lancet. Infectious Diseases|July 27, 2019
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trialJoshua Rhein, Kathy Huppler Hullsiek, Lillian Tugume, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases|February 12, 2020
Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and OutcomesKatelyn A Pastick, Ananta S Bangdiwala, Mahsa Abassi, et al.
Open Forum Infectious Diseases|May 13, 2022
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient TrialsSarah M Lofgren, Elizabeth C Okafor, Alanna A Colette, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases PharmacistsElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Pharmacotherapy|July 15, 2024
Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists: An executive summaryElizabeth M Sherman, Allison L Agwu, Juan Ambrosioni, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
A national survey of the infectious diseases and antimicrobial stewardship pharmacist workforce in the United States: work settings, characteristics, employment activities, resources and needsElizabeth B Hirsch, David A Mott, Aaron M Gilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical TrialMorris K Rutakingirwa, Caleb P Skipper, Biyue Dai, et al.
The New England Journal of Medicine|June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Pageof 15